MOCS1 Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9NZB8 |
---|---|
Clone Names | 110826260 |
Gene ID | 4337 |
---|---|
Other Names | Molybdenum cofactor biosynthesis protein 1, Cell migration-inducing gene 11 protein, Molybdenum cofactor synthesis-step 1 protein A-B, Cyclic pyranopterin monophosphate synthase, Molybdenum cofactor biosynthesis protein A, Cyclic pyranopterin monophosphate synthase accessory protein, Molybdenum cofactor biosynthesis protein C, MOCS1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MOCS1 |
---|---|
Function | Isoform MOCS1A and isoform MOCS1B probably form a complex that catalyzes the conversion of 5'-GTP to cyclic pyranopterin monophosphate (cPMP). MOCS1A catalyzes the cyclization of GTP to (8S)- 3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate and MOCS1B catalyzes the subsequent conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'- triphosphate to cPMP. |
Tissue Location | Isoform MOCS1A and isoform 2 are widely expressed. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Molybdenum cofactor biosynthesis is a conserved pathwayleading to the biological activation of molybdenum. The proteinencoded by this gene is involved in this pathway. This gene wasoriginally thought to produce a bicistronic mRNA with the potentialto produce two proteins (MOCS1A and MOCS1B) from adjacent openreading frames. However, only the first open reading frame (MOCS1A)has been found to encode a protein from the putative bicistronicmRNA, whereas additional splice variants, whose full-length natureshave yet to be determined, are likely to produce a fusion betweenthe two open reading frames. This gene is defective in patientswith molybdenum cofactor deficiency, type A. A related pseudogenehas been identified on chromosome 16.
References
Sass, J.O., et al. Brain Dev. (2009) In press :Arenas, M., et al. J. Inherit. Metab. Dis. 32(4):560-569(2009)Ichida, K., et al. Nucleosides Nucleotides Nucleic Acids 25 (9-11), 1087-1091 (2006) :Macaya, A., et al. Neuropediatrics 36(6):389-394(2005)Leimkuhler, S., et al. Hum. Genet. 117(6):565-570(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.